Core Viewpoint - Silvaco Group, Inc. (SVCO) is anticipated to report flat earnings with a quarterly loss of $0.06 per share, while revenues are expected to increase by 46.5% to $16.07 million compared to the previous year [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for November 12, and the stock may rise if the actual results exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised 280% higher in the last 30 days, indicating a significant reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows that the Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [12]. - The stock currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [13]. Historical Performance - In the last reported quarter, Silvaco Group was expected to post a loss of $0.09 per share but actually reported a loss of $0.16, resulting in a surprise of -77.78% [14]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [15]. Conclusion - Silvaco Group, Inc. does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding this stock ahead of the earnings release [18].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Smith Micro Software, Inc. despite lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $0.13 per share, reflecting a year-over-year improvement of +56.7% [3]. - Expected revenues are projected at $4.4 million, which is a decline of 5.4% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 5% higher in the last 30 days, indicating a reassessment by analysts [4]. - It is important to note that the direction of estimate revisions may not always align with the overall change in consensus estimates [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, suggesting that recent revisions may provide more accurate predictions [8]. - A positive Earnings ESP reading is a strong indicator of potential earnings beats, especially when combined with a favorable Zacks Rank [10].

Core Viewpoint - Bolt Biotherapeutics, Inc. (BOLT) is anticipated to report a year-over-year increase in earnings despite lower revenues for the quarter ending September 2025, with actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $5.07 per share, reflecting a year-over-year change of +36.6%, while revenues are projected to be $0.77 million, down 32.5% from the previous year [3]. - The consensus EPS estimate has been revised 0.83% lower in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows that the Most Accurate Estimate for Bolt Biotherapeutics is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +0.33%, suggesting a bullish outlook on earnings prospects [12]. - The stock currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Bolt Biotherapeutics was expected to post a loss of $6.4 per share but actually reported a loss of -$4.46, achieving a surprise of +30.31% [13]. - Over the past four quarters, the company has surpassed consensus EPS estimates two times [14]. Industry Context - In the Zacks Medical - Biomedical and Genetics industry, Protagonist Therapeutics (PTGX) is expected to report a loss of $0.59 per share for the same quarter, with a year-over-year change of -9.3% and projected revenues of $10 million, up 113.7% from the previous year [18][19]. - Protagonist Therapeutics has a higher Most Accurate Estimate leading to an Earnings ESP of +29.92%, suggesting a strong likelihood of beating the consensus EPS estimate [19][20].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Ovid Therapeutics, driven by higher revenues, but actual results compared to estimates will significantly influence the stock price [1][2]. Earnings Expectations - Ovid Therapeutics is expected to report a quarterly loss of $0.15 per share, reflecting a year-over-year change of +25% [3]. - Revenues are projected to be $0.34 million, representing a 100% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 5.26% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Ovid is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -4.50%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, with positive readings being more reliable [9][10]. - Ovid's current Zacks Rank is 3, which complicates predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Ovid was expected to post a loss of $0.16 per share but actually reported a loss of -$0.06, achieving a surprise of +62.50% [13]. - Over the past four quarters, Ovid has beaten consensus EPS estimates two times [14]. Industry Context - Avidity Biosciences, a peer in the Zacks Medical - Biomedical and Genetics industry, is expected to report a loss of $1.05 per share, indicating a year-over-year change of -61.5% [18]. - Avidity's revenue is expected to be $2.5 million, up 6.8% from the previous year, but it also has a negative Earnings ESP of -9.35% [19][20].

Core Viewpoint - The market anticipates that Sky Harbour Group Corporation (SKYH) will report flat earnings compared to the previous year, with revenues expected to increase significantly [1][3]. Earnings Expectations - The consensus EPS estimate for Sky Harbour Group is a loss of $0.10 per share, unchanged from the year-ago quarter, while revenues are projected to be $8.63 million, reflecting a 110.5% increase year-over-year [3]. - The earnings report could lead to a stock price increase if actual results exceed expectations, but a miss could result in a decline [2]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 25%, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][12]. - The Most Accurate Estimate for Sky Harbour Group is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -10.00% [12]. Historical Performance - In the last reported quarter, Sky Harbour Group was expected to post a loss of $0.12 per share but actually reported a loss of $0.10, achieving a surprise of +16.67% [13]. - The company has beaten consensus EPS estimates three times over the last four quarters [14]. Comparative Analysis - Rocket Lab Corporation (RKLB), another player in the aerospace-defense equipment industry, is expected to report a loss of $0.05 per share, with revenues projected at $149.82 million, a 42.9% increase year-over-year [18][19]. - Rocket Lab's consensus EPS estimate has remained unchanged, but a higher Most Accurate Estimate gives it an Earnings ESP of +25.00%, indicating a likely beat of the consensus EPS estimate [19][20].

Core Viewpoint - Wall Street anticipates flat earnings for SKYX Platforms Corp. with a projected quarterly loss of $0.08 per share and revenues of $23.2 million, reflecting a 4.7% increase year-over-year [1][3]. Earnings Expectations - The consensus EPS estimate has been revised down by 33.33% over the last 30 days, indicating a reassessment by analysts [4]. - A positive or negative Earnings ESP reading can indicate the likely deviation of actual earnings from the consensus estimate, with a positive reading being a strong predictor of an earnings beat [9][10]. Earnings Surprise Prediction - The Most Accurate Estimate for SKYX is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, making it challenging to predict an earnings beat [12]. - SKYX currently holds a Zacks Rank of 3, which does not strongly indicate an earnings beat [12]. Historical Performance - In the last reported quarter, SKYX matched the expected loss of $0.08 per share, resulting in no surprise [13]. - Over the past four quarters, SKYX has beaten consensus EPS estimates twice [14]. Industry Comparison - Bitdeer Technologies Group (BTDR) is expected to report a loss of $0.22 per share, a year-over-year change of +37.1%, with revenues projected at $161.14 million, up 159.8% from the previous year [18][19]. - The consensus EPS estimate for Bitdeer has been revised 40% higher in the last 30 days, with a positive Earnings ESP of +27.27%, suggesting a likely earnings beat [19][20].

Core Viewpoint - Somnigroup International (SGI) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on November 6, with a consensus EPS estimate of $0.85 per share, reflecting a year-over-year increase of +3.7% [3]. - Revenues are projected to reach $2.07 billion, representing a substantial increase of 59% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 4.17% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for SGI is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.53%, suggesting a bullish outlook on the company's earnings prospects [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10]. - SGI currently holds a Zacks Rank of 2, enhancing the likelihood of beating the consensus EPS estimate [12]. Historical Performance - SGI has a history of exceeding consensus EPS estimates, having beaten expectations in the last four quarters [14]. - In the last reported quarter, SGI was expected to post earnings of $0.51 per share but delivered $0.53, resulting in a surprise of +3.92% [13]. Conclusion - While SGI is positioned as a compelling earnings-beat candidate, it is essential to consider other factors that may influence stock performance beyond earnings results [15][17].

Core Insights - Arcellx, Inc. (ACLX) is anticipated to report a year-over-year decline in earnings due to lower revenues for the quarter ended September 2025, with a consensus EPS estimate of a loss of $0.96 per share, reflecting a -100% change [1][3] - Revenues are projected to be $14.64 million, down 43.8% from the same quarter last year [3] - The consensus EPS estimate has been revised 12.39% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Expectations - The upcoming earnings report could lead to a stock price increase if results exceed expectations, while a miss could result in a decline [2] - The Earnings Whisper model suggests that revisions prior to earnings releases provide insights into business conditions [7] Earnings Surprise Prediction - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with a positive Earnings ESP indicating a likely earnings beat [8][9] - For Arcellx, the Most Accurate Estimate is higher than the consensus, resulting in an Earnings ESP of +7.60%, suggesting a strong likelihood of beating the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Arcellx was expected to post a loss of $1.03 per share but actually reported a loss of -$0.94, achieving a surprise of +8.74% [13] - Over the past four quarters, Arcellx has beaten consensus EPS estimates two times [14] Industry Context - Another company in the biomedical sector, Geron (GERN), is expected to report a loss of $0.03 per share, indicating a year-over-year change of +25%, with revenues projected at $52.49 million, up 85.7% [18] - Geron's consensus EPS estimate has been revised 7.7% lower, resulting in an Earnings ESP of -32.35%, combined with a Zacks Rank of 4 (Sell), making it challenging to predict an earnings beat [19][20]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for MP Materials Corp. due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Company Summary - The upcoming earnings report for MP Materials is expected to show a quarterly loss of $0.14 per share, reflecting a year-over-year change of -16.7% [3]. - Revenues are projected to be $53.14 million, down 15.6% from the same quarter last year [3]. - The consensus EPS estimate has been revised 13.04% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for MP Materials is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +8.77%, suggesting a likelihood of beating the consensus EPS estimate [12]. Earnings Surprise History - In the last reported quarter, MP Materials was expected to post a loss of $0.17 per share but actually reported a loss of -$0.13, resulting in a positive surprise of +23.53% [13]. - Over the last four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Context - In the Zacks Mining - Miscellaneous industry, Ur Energy is expected to post a loss of $0.03 per share, indicating a year-over-year change of -50% [18]. - Ur Energy's revenue is expected to be $6.83 million, up 6.7% from the previous year [18]. - The consensus EPS estimate for Ur Energy has been revised 33.3% lower in the last 30 days, resulting in an Earnings ESP of -12.50%, making it difficult to predict a beat on the consensus EPS estimate [19].

Core Insights - Eos Energy Enterprises, Inc. (EOSE) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended September 2025, with a consensus estimate of a loss of $0.29 per share, reflecting a 34.1% improvement from the previous year [1][3] - Revenues are projected to reach $39.81 million, representing a significant increase of 4583.5% compared to the same quarter last year [3] - The earnings report is anticipated to be released on November 5, and the actual results will be crucial in determining the stock's near-term price movement [2] Estimate Revisions Trend - The consensus EPS estimate has been revised 6.86% higher in the last 30 days, indicating a collective reassessment by analysts [4] - Despite the upward revision, the Most Accurate Estimate for Eos Energy is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -53.85%, suggesting a bearish outlook from analysts [12] Earnings Surprise History - In the last reported quarter, Eos Energy was expected to post a loss of $0.17 per share but instead reported a loss of $1.05, resulting in a surprise of -517.65% [13] - The company has not been able to beat consensus EPS estimates in any of the last four quarters, indicating a consistent trend of underperformance [14] Bottom Line - Eos Energy does not appear to be a compelling candidate for an earnings beat, and investors should consider other factors when making decisions regarding this stock ahead of its earnings release [17]